Fertility journey of a patient with McCune-Albright syndrome associated with bilateral ovarian involvement

被引：0
作者：
Kim, Joanna J. [1 ]
Dufour, Stephanie [1 ,2 ]
Awad, Sara [3 ]
Magee, Bryden [1 ,2 ]
机构：
[1] Univ Ottawa, Dept Obstet & Gynecol, 501 Smyth Rd,Room 8168, Ottawa, ON K1H 8L6, Canada
[2] Ottawa Fertil Clin, Ottawa, ON, Canada
[3] Queens Univ, Dept Med, Div Endocrinol & Metab, Kingston, ON, Canada
来源：
F&S REPORTS | 2024年 / 5卷 / 04期
关键词：
McCune-Albright syndrome; recurrent ovarian cysts; in vitro fertilization (IVF); PREGNANCY; DYSFUNCTION; INFERTILITY; EXPERIENCE;
D O I：
10.1016/j.xfre.2024.08.006
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Objective: To report a patient with McCune-Albright syndrome (MAS) with bilateral ovarian involvement who had achieved a pregnancy through in vitro fertilization (IVF). Design: Case report. Setting: Academic fertility center. Patient(s): A 33-year-old female with McCune-Albright syndrome who presented with primary infertility because of ovulatory dysfunction secondary to excessive secretion of growth hormone in addition to autonomous estrogen secretion by her ovaries. Exposure: In vitro fertilization and near-normalization of insulin-like growth factor-1 (IGF-1) using somatostatin analogue lanreotide. Main Outcome Measure(s): Reproductive outcomes after medical treatment for MAS-associated anovulatory infertility involving bilateral MAS ovarian involvement and growth hormone excess. Result(s): Spontaneous ovulation was resumed in this patient using lanreotide which regulated IGF-1 levels after unsuccessful ovulation induction with letrozole. Despite documented ovulation, she failed to conceive and subsequently, underwent an IVF cycle using an antagonist cycle with recombinant follicular stimulating hormone and recombinant luteinizing hormone stimulation. A total of 13 oocytes were retrieved and three good quality blastocysts were cryopreserved. Two frozen embryo transfer cycles were completed and she achieved a pregnancy, which unfortunately ended in an incomplete miscarriage. Conclusion(s): Through IVF and near-normalization of IGF-1 using lanreotide, pregnancy was achieved in a patient with MAS who had achieved good ovarian stimulation despite a history of bilateral ovarian involvement and associated hyperfunctioning endocrinopathies. (F S Rep (R) 2024;5:453-7. (c) 2024 by American Society for Reproductive Medicine.)
引用
收藏
页码：453 / 457
页数：5
相关论文
共 19 条
  • [11] Chanson P., Salenave S., Young J., Ovarian dysfunction by activating mutation of GS alpha: McCune-Albright syndrome as a model, Ann Endocrinol (Paris), 71, pp. 210-213, (2010)
  • [12] Cheng S., Grasso L., Martinez-Orozco J.A., Al-Agha R., Pivonello R., Colao A., Et al., Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature, Clin Endocrinol (Oxf), 76, pp. 264-271, (2012)
  • [13] Jiao R., Ju J., Wang L., Yang H., Yao Y., Deng K., Et al., Safety of pregnancy in acromegaly patients and maternal and infant outcomes after pregnancy: single-center experience from China and review of the literature, BMC Endocr Disord, 23, (2023)
  • [14] Assal A., Malcolm J., Lochnan H., Keely E., Preconception counselling for women with acromegaly: more questions than answers, Obstet Med, 9, pp. 9-14, (2016)
  • [15] Collins M.T., Singer F.R., Eugster E., McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia, Orphanet J Rare Dis, 7, (2012)
  • [16] Katznelson L., Laws E.J., Melmed S., Molitch M.E., Murad M.H., Utz A., Et al., Acromegaly: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, 99, pp. 3933-3951, (2014)
  • [17] Anderlova K., Cinkajzlova A., Simjak P., Klouckova J., Kratochvilova H., Lacinova Z., Et al., Association between gestational diabetes mellitus and bioavailability of insulin-like growth factors and role of their binding proteins, Growth Horm IGF Res, 67, (2022)
  • [18] Scaravelli G., Zaca C., Levi Setti P.E., Livi C., Ubaldi F.M., Villani M.T., Et al., Fertilization rate as a novel indicator for cumulative live birth rate: a multicenter retrospective cohort study of 9,394 complete in vitro fertilization cycles, Fertil Steril, 116, pp. 766-773, (2021)
  • [19] Stone B.A., March C.M., Ringler G.E., Baek K.J., Marrs R.P., Casting for determinants of blastocyst yield and of rates of implantation and of pregnancy after blastocyst transfers, Fertil Steril, 102, pp. 1055-1064, (2014)
12